Discontinue use and consult a medical doctor immediately if you experience unusual symptoms. Consult a medical doctor before use if you have been treated for, or diagnosed with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. Consult a medical doctor before starting any diet or exercise program. Improper use of this product will not improve results and is not advised. Use only as directed.
The glutamatergic system is integral to development and maintenance of neuropathic pain, and is responsible for generating secondary and tertiary hyperalgesia in migraine and fibromyalgia via NMDA mechanisms (Nicolodi et al 1998). Thus, it is important to note that cannabinoids presynaptically inhibit glutamate release (Shen et al 1996), THC produces 30%–40% reduction in NMDA responses, and THC is a neuroprotective antioxidant (Hampson et al 1998). Additionally, cannabinoids reduce hyperalgesia via inhibition of calcitonin gene-related peptide (Richardson et al 1998a). As for Substance P mechanisms, cannabinoids block capsaicin-induced hyperalgesia (Li et al 1999), and THC will do so at sub-psychoactive doses in experimental animals (Ko and Woods 1999). Among the noteworthy interactions with opiates and the endorphin/enkephalin system, THC has been shown to stimulate beta-endorphin production (Manzanares et al 1998), may allow opiate sparing in clinical application (Cichewicz et al 1999), prevents development of tolerance to and withdrawal from opiates (Cichewicz and Welch 2003), and rekindles opiate analgesia after a prior dosage has worn off (Cichewicz and McCarthy 2003). These are all promising attributes for an adjunctive agent in treatment of clinical chronic pain states.
“We continue to estimate a $250-500B potential long-term global cannabis market, with a $15-50B near-term opportunity,” analysts Michael Lavery and Jeffrey Kratky wrote in a note. “We expect intellectual property, value-added products, and form factor evolution to be key long-term drivers for the company.” Piper Jaffray rates the stock as overweight with a $60 price target, equal to 33% upside from its current trading level.
Yes, Hemp Bombs CBD Rub is federally legal to buy and sell. The CBD infused into our Pain Rub is sourced from Industrial Hemp, a plant that contains high levels of CBD and low levels of THC. We then isolate our CBD through the CO2 Extraction process. The CO2 Extraction Process allows us to attain a pure and THC-free topical product that can benefit your health.
Hemp Oil is processed from the seeds and stalks of the hemp plant and despite its source, it contains little to none of the psychoactive element Tetrahydrocannabinol (THC), meaning it cannot get you ‘high’. For instance hemp may contain 0.3-1.5% of THC whilst marijuana contains anything from 5% to 20% plus. Hemp oils main components are in fact omega fatty acids, similar to those which can be found in fish and olive oil.
First of all, you need to know that CBD oil can come from both the hemp plant and from medical marijuana. Both of those plants are different varieties of cannabis but they’re much different in the terms of chemical compounds they have. Medical marijuana is good for people with certain ailments because it does contain the THC and it can contain any varying level of the THC or any varying level of CBD.